The global hereditary angioedema therapeutics market size was estimated at USD 3.60 billion in 2025 and is projected to reach USD 8.18 billion by 2033, growing at a CAGR of 10.43% from 2026 to 2033. The global hereditary angioedema therapeutics market is expanding due to increasing diagn... Read More »
March 2026The global pharmaceutical manufacturing market size was estimated at USD 616.15 billion in 2025 and is projected to reach USD 990.55 billion by 2033, growing at a CAGR of 5.88% from 2026 to 2033. The market is driven by demand for advanced therapeutics, biologics, and high-volume generic... Read More »
March 2026The global alpha-gal syndrome allergy market size was valued at USD 78.0 million in 2025 and is projected to grow from USD 84.2 million in 2026 to USD 147.9 billion by 2033, at a CAGR of 8.4% from 2026 to 2033.North America alpha-gal syndrome allergy market held the largest share of 83.9... Read More »
February 2026The Australia medical cannabis market size was estimated at USD 595.12 million in 2025 and is projected to reach USD 1,637.44 million by 2033, growing at a CAGR of 12.85% from 2026 to 2033. This growth is driven by a rising interest in alternative therapies for managing chronic pain, nau... Read More »
February 2026The Australia legal cannabis market size was estimated at USD 862.31 million in 2025 and is anticipated to reach USD 3.05 billion by 2033, growing at a CAGR of 16.19% from 2026 to 2033. The industry is driven by growing awareness of the health benefits of cannabis and the growing legaliz... Read More »
February 2026The U.S. complementary and alternative medicine market size was estimated at USD 52.78 billion in 2025 and is projected to reach USD 375.51 billion by 2033, growing at a CAGR of 27.8% from 2026 to 2033. The market growth can be attributed to the increasing prevalence of chronic diseases,... Read More »
January 2026The UK prescription weight loss medications market size was estimated at USD 421.07 million in 2025 and is projected to reach USD 2,485.23 million by 2033, growing at a CAGR of 24.85% from 2026 to 2033. Growth is driven by rising obesity prevalence, increasing clinical adoption of incret... Read More »
December 2025The U.S. longevity & general wellness supplements market size was valued at USD 6.35 billion in 2025 and is anticipated to reach USD 10.13 billion by 2033, expanding at a CAGR of 6.06% from 2026 to 2033. This sustained growth is driven by rising consumer awareness around preventive h... Read More »
December 2025The U.S. plant-based API market size was estimated at USD 9.69 billion in 2024 and is projected to reach USD 15.77 billion by 2033, growing at a CAGR of 5.5% from 2025 to 2033. The market is witnessing strong growth due to the increasing adoption of natural and sustainable pharmaceutical... Read More »
December 2025The global plant-based API market size was estimated at USD 31.78 billion in 2024 and is projected to reach USD 53.21 billion by 2033, growing at a CAGR of 5.9% from 2025 to 2033. The market is progressing steadily as pharmaceutical companies shift toward natural-origin ingredients suppo... Read More »
December 2025The global breast cancer drugs market size was estimated at USD 36.62 billion in 2024 and is projected to reach USD 69.72 billion by 2033, growing at a CAGR of 7.09% from 2025 to 2033. The market is driven by several critical factors, including the increasing global incidence of breast c... Read More »
December 2025The global insomnia supplements market size was valued at USD 4.3 billion in 2024 and is projected to grow from USD 5.3 billion in 2026 to USD 12.6 billion by 2033, at a CAGR of 12.9% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 36.5% in 2024.... Read More »
November 2025The U.S. autism spectrum disorder treatment market size was estimated at USD 827.84 million in 2024 and is projected to reach USD 1,431.60 million by 2033, growing at a CAGR of 6.30% from 2025 to 2033. The increasing diagnosis rates and wider access to therapeutic services drive the grow... Read More »
November 2025The Middle East bone and joint health supplements market size was estimated at USD 262.7 million in 2024 and is projected to reach USD 408.7 million by 2033, growing at a CAGR of 5.04% from 2025 to 2033. Market growth is driven by the rising prevalence of osteoporosis and joint disorders... Read More »
November 2025The U.S. osteoarthritis therapeutics market size was estimated at USD 2.15 billion in 2024 and is projected to reach USD 4.50 billion by 2033, growing at a CAGR of 8.61% from 2025 to 2033. Growing geriatric population, rising prevalence of obesity and joint injuries, and increasing deman... Read More »
November 2025The global urinary incontinence therapeutics market size was valued at USD 4.3 billion in 2024 and is projected to grow from USD 4.8 billion in 2026 to USD 6.9 billion by 2033, at a CAGR of 5.4% from 2025 to 2033. North America dominated the market, accounting for a revenue share of 40.1... Read More »
November 2025The global immune health supplements market size was estimated at USD 35.4 billion in 2024 and is projected to reach USD 76.2 billion by 2033, growing at a CAGR of 9.1% from 2025 to 2033. The key factors driving market growth include the increasing prevalence of infectious diseases, diab... Read More »
November 2025The Saudi Arabia total parenteral nutrition market size was valued at USD 94.64 million in 2024 and is projected to USD 155.64 million by 2033, growing at a CAGR of 5.71% from 2025 to 2033. The rising prevalence of chronic diseases and the increasing number of premature births are signif... Read More »
November 2025The U.S. urinary incontinence therapeutics market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 2.41 billion by 2033, growing at a CAGR of 5.06% from 2025 to 2033. The U.S. market is expanding as demand for advanced treatment options rises across key patien... Read More »
November 2025The U.S. leukemia therapeutics market size was estimated at USD 7.23 billion in 2024 and is projected to reach USD 13.07 billion by 2033, growing at a CAGR of 6.80% from 2025 to 2033. The industry is expanding due to the strong adoption of targeted therapies that offer high clinical prec... Read More »
November 2025